ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced findings from a national survey of military service members and veterans with non-muscle invasive bladder ...
(NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced members of the senior leadership team will speak at ...
BOSTON & MONTREAL, November 11, 2026--enGene Therapeutics Inc. (Nasdaq: ENGN) ("enGene" or the "Company"), a clinical-stage, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results